Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00719589 · ClinicalTrials.gov registry record

Outcomes of Pudendal InterStim

A clinical trial, sponsored by Corewell Health East.

Completed
Registry status
84
Enrollment target

NCT00719589 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00719589 has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
84 participants
Enrollment target

Study Summary

The purpose of this study is to determine how many patients who have failed treatment with a sacral lead can achieve good results with a pudendal, patients satisfaction with the results of each lead, complication rates after pudendal lead placement, and how many patients have required reprogramming of their device with EMG testing( a more costly procedure).

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2008-07
Est. Completion 2010-01

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT00719589

The ClinicalTrials.gov registry entry for NCT00719589 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00719589 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00719589 about?

NCT00719589 is a clinical study titled "Outcomes of Pudendal InterStim". The purpose of this study is to determine how many patients who have failed treatment with a sacral lead can achieve good results with a pudendal, patients satisfaction with the results of each lead, complication rates after pudendal lead placement, and how many patients have required reprogramming ...

What is the current status of trial NCT00719589?

This trial is currently completed. The enrollment target is 84 participants. The study started on 2008-07. Estimated completion is 2010-01.

Who is sponsoring clinical trial NCT00719589?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.